Centene Corporation (NYSE:CNC) has been making headlines recently, especially after the financial results of a major health insurer sent the Dow index lower. Jim Cramer, the renowned stock market expert, discussed the turmoil in the healthcare sector on CNBC’s Squawk on the Street and speculated about potential government scrutiny in the wake of the November 2024 US Presidential election.
Cramer highlighted the pressure on healthcare stocks towards the end of last year when the President-elect had promised to take on the healthcare middleman. He warned viewers against buying stocks of some of the largest healthcare benefits management companies, expressing concerns about potential government interventions.
However, as time progressed, Cramer’s concerns seemed to diminish. In a February appearance following Trump’s inauguration, he pondered whether the Trump administration’s Justice Department was equipped to take on American healthcare giants. Despite hedge fund manager Bill Ackman advising against buying healthcare stocks, Cramer seemed less apprehensive about the situation.
In a recent discussion, Cramer raised the question of whether tighter government scrutiny of the companies’ coding practices could impact their loss ratios and potentially drive them higher. He mentioned concerns about the Justice Department’s focus on healthcare companies and their potential impact on the market.
Centene Corporation (NYSE:CNC) emerged as a significant player in the healthcare sector, particularly in terms of Medicaid. Despite challenges in the industry, Cramer noted that Centene is performing exceptionally well. The stock has shown resilience amidst market volatility, with shares down only 3.7% year-to-date.
In the grand scheme of things, CNC ranks 2nd on the list of stocks that Jim Cramer discusses, indicating its significance in the current market landscape. With 71 hedge fund holders in Q4 2024, Centene Corporation remains a key player in the healthcare insurance sector.
Overall, Centene Corporation’s performance and position in the market showcase its resilience and potential for growth amidst challenging times in the healthcare industry. As investors navigate through market uncertainties, keeping an eye on stocks like CNC can provide valuable insights into the ever-changing landscape of the healthcare sector. When considering investments in the tech sector, it’s important to look beyond traditional options like CNC and explore the potential of AI stocks. While CNC certainly has its merits, there are AI stocks that show even greater promise for delivering higher returns in a shorter time frame.
One particular AI stock has seen a significant increase since the beginning of 2025, while other popular AI stocks have experienced losses of around 25%. For investors seeking a more promising option than CNC, there is a report available on the Insider Monkey website highlighting the potential of the cheapest AI stock currently trading at less than 5 times its earnings.
This undervalued AI stock is poised for massive gains, with a potential upside of 10,000%. By investing in this promising AI stock, investors may be able to capitalize on the growing trend of artificial intelligence technology and achieve substantial returns on their investment.
For more information on the best AI stocks to buy now, check out the comprehensive list of the 20 Best AI Stocks To Buy Now and the 30 Best Stocks to Buy Now According to Billionaires on the Insider Monkey website. These resources provide valuable insights and analysis to help investors make informed decisions about their investment portfolios.
It’s important to note that this article is for informational purposes only and does not constitute financial advice. Investors should conduct their own research and consult with a financial advisor before making any investment decisions. For more information and updates on the latest investment opportunities, visit the Insider Monkey website.
